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Abstract
Background:  Golgins are coiled-coil proteins associated with the Golgi apparatus, that are
believed to be involved in the tethering of vesicles and the stacking of cisternae, as well as other
functions such as cytoskeletal association. Many are peripheral membrane proteins recruited by
GTPases. Several have been described in animal cells, and some in yeast, but the relationships
between golgins from different species can be hard to define because although they share structural
features, their sequences are not well conserved.
Results: We show here that the yeast protein Sgm1, previously shown to be recruited to the Golgi
by the GTPase Ypt6, binds to Ypt6:GTP via a conserved 100-residue coiled-coil motif that can be
identified in a wide range of eukaryotes. The mammalian equivalent of Sgm1 is TMF/ARA160, a
protein previously identified in various screens as a putative transcription or chromatin remodelling
factor. We show that it is a Golgi protein, and that it binds to the three known isoforms of the
Ypt6 homologue Rab6. Depletion of the protein by RNA interference in rat NRK cells results in a
modest dispersal of Golgi membranes around the cell, suggesting a role for TMF in the movement
or adherence of Golgi stacks.
Conclusion: We have identified TMF as an evolutionarily conserved golgin that binds Rab6 and
contributes to Golgi organisation in animal cells.
Background
Golgins are coiled-coil proteins that are associated with
the Golgi apparatus and contribute to its organisation and
function (for full review and references see [1]). Some,
such as CASP and golgin-84, have a C-terminal transmem-
brane anchor, whereas others are peripheral proteins.
There is evidence that some of them are tethers that help
vesicles to dock with Golgi membranes, a good example
being the yeast Uso1 protein and its mammalian homo-
logue p115, which are implicated in ER-Golgi traffic [2,3].
Yeast Imh1 also plays a role in vesicle traffic to the Golgi
[4]. Others have been suggested to link Golgi cisternae,
stabilising their stacked morphology, or to act as scaffolds
that hold Golgi-associated proteins with regulatory func-
tions [1]. The golgins Bicaudal-D1 and -D2 are thought to
link vesicles to the cytoskeleton [5]. Other functions have
also been suggested – for example, some golgins might
serve to protect membranes from inappropriate fusion
events.
Several peripheral golgins have been shown to be
anchored to Golgi membranes by association with Rab
GTP-binding proteins, the binding site on the golgin often
being part of the coiled-coil region. Thus for example
Uso1/p115 binds to Ypt1/Rab1 [2,3], golgin-45 binds
Rab2 [6], and Bicaudal-D binds Rab6 [5]. Other golgins
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such as Imh1, golgin-97 and golgin-240 share a small
GRIP domain at their extreme C terminus, which binds to
the GTPase Arl1 and serves to anchor them on Golgi
membranes [1,7].
Coiled-coils often have a structural or spacer function,
and as such are not necessarily well-conserved in evolu-
tion. Furthermore, their common amphipathic nature
means that homology searches can be confusing, all long
stretches of coiled-coil showing a superficial similarity.
Thus, while some yeast and mammalian golgins share
clear structural and functional homology, others are less
obviously related.
Our previous studies on the yeast Rab6-like GTPase Ypt6
led to the identification of a protein, Sgm1, that can bind
the GTP form of Ypt6 and has the characteristic extensive
coiled-coil motifs of a golgin [8]. Moreover, Sgm1 is
recruited to Golgi membranes in vivo by Ypt6 [8]. To
identify a mammalian homologue, we have localised the
Ypt6 binding site and looked for proteins with homology
to this region of the protein. This approach identified
TMF1/ARA160, which we show to be both localised to the
Golgi and capable of binding to all three known isoforms
of Rab6. Reduction of the levels of TMF protein by RNAi
treatment of NRK cells resulted in an apparent loosening
of the overall Golgi structure, with Golgi stacks being
spread over a larger area than normal, consistent with a
role for the protein in movement, anchoring or tethering
of Golgi membranes. TMF1/ARA160 was previously iden-
tified by various interaction screens as a DNA-binding
protein [9], a hormone receptor co-activator [10] and a
component of a chromatin remodelling complex [11].
However, our results provide clear evidence that it
behaves as a typical golgin.
Results
Mapping the Ypt6-binding domain of Sgm1
Sgm1 is predicted to have four distinct domains: a long
coiled-coil region from about residue 130 to 488, a
shorter C terminal coiled-coil from 597 to 707, and non-
coiled domains from 1–130 and 488–597 (Figure 1A). We
expressed, from the SGM1 promoter in yeast, fusion pro-
teins containing a C-terminal Protein A tag and either full-
length Sgm1, or residues 1–488, 488–707 or 597–707.
The latter two fragments were expressed less well, but
from a multicopy vector they yielded comparable
amounts of protein to the full length and 1–488 fragment,
which were expressed from a centromere plasmid (Figure
1B).
Cell extracts were then incubated with beads containing
GST-Ypt6, loaded either with GDP or GTPγS, as previously
described [8]. Bound proteins were eluted and detected by
immunoblotting. As shown in Figure 1B, the full-length
Sgm1-protein A bound preferentially to the GTP form of
Ypt6, though there was also considerable proteolysis to
yield smaller C-terminal fragments that also seemed to
bind Ypt6-GTP. The 1–488 fragment did not bind at all to
Ypt6. The 488–707 fragment again bound but was exten-
sively degraded, whereas the 597–707 fragment, compris-
ing just the C-terminal coiled coil, bound strongly and
selectively to Ypt6-GTP. Indeed, this fusion protein corre-
sponded in size to the smallest prominent Ypt6-binding
fragment derived by proteolysis from the full-length and
488–707 constructs. We conclude that the C terminal
coiled-coil domain contains the Ypt6 binding site of
Sgm1.
TMF is related to Sgm1 and binds Rab6
Using the last 110 residues of Sgm1 we performed itera-
tive BLAST searches and identified clear homologues in
other fungi, plants, Drosophila and also in mouse and
human. As shown in Figure 2A, the uncharacterised pro-
tein sequences from Neurospora, Arabopsis, and Dro-
sophila all share with yeast Sgm1 a similar overall
structure consisting of a large coiled-coil region, flanked
by short non-coil domains, with a separate short coiled-
coil region at the C terminus. The human protein with the
strongest similarity to this region is called TMF, for TATA
element modulatory factor (Figure 2). Like Sgm1, TMF is
a large protein (1093 residues) predicted to consist
mainly of coiled-coil. Perhaps significantly, TMF and the
other proteins were selected only when the C terminal
Ypt6-binding region was included in the homology
search. Other parts of Sgm1 seemed no more similar to
TMF than they were to other coiled-coil proteins such as
myosin. Similarly, there seemed little conservation
between species of the non-coil parts of the protein. Fig-
ure 2B shows an alignment of the sequences of the C ter-
minal coiled-coil regions of the various homologues.
To be able to test whether TMF can bind other proteins,
we sought to express it in bacteria. It proved difficult to
obtain the full-length protein in E. coli, but we were able
to prepare a His-tagged fragment consisting of the C-ter-
minal 310 residues, which includes the region with simi-
larity to Sgm1.
The mammalian homologue of Ypt6 is Rab6, which exists
in three forms: Rab6A, Rab6A' (a variant differing from
Rab6A only at three residues), and a more divergent
Rab6B [12,13]. We produced each of these as GST fusion
proteins and performed binding studies with the TMF C
terminal fragment. As controls we used GST-Rab1, and
also a GST fusion of the yeast protein Ypt52. As shown in
Figure 3, TMF bound to all three isoforms of Rab6. There
was a preference for the GTP form, though this was mod-
est and quite variable, a phenomenon that is not uncom-
mon amongst Rab effectors. Specificity was demonstratedBMC Cell Biology 2004, 5 http://www.biomedcentral.com/1471-2121/5/18
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Mapping the Ypt6 binding site on Sgm1 Figure 1
Mapping the Ypt6 binding site on Sgm1 A. Coiled-coil probabilities of the Sgm1 protein sequence, calculated by the 
method of Lupas using the coils program. The regions analysed for binding are shown diagrammatically below. B. Immunoblot 
with anti-Protein A of the indicated portions of Sgm1 bound to and eluted from GST-Ypt6 in the GTP and GDP state. Input 
samples are yeast extract corresponding to about 1% of the total input. The intact protein A fusions are indicated by the 
arrowheads. Asterisks mark C terminal proteolytic fragments, still fused to protein A, that are common to both the full-length 
and 488–707 constructs; note that the smallest visible fragment corresponds closely to the 597–707 construct. Proteins appar-
ently larger than the input in the 488–707 lanes presumably represent dimers and other aggregates.
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by the complete lack of binding to Rab1 or Ypt52. These
results indicate that TMF is indeed a homologue of Sgm1,
and shares its ability to bind a Golgi Rab protein.
Sgm1 homologues are present in a wide range of eukaryotes Figure 2
Sgm1 homologues are present in a wide range of eukaryotes A. Coiled-coil predictions for various Sgm1-like proteins. 
Note that each has a distinct 100-residue coiled-coil domain at the C terminus, which in Sgm1 corresponds to the Ypt6-binding 
domain. The regions of TMF used for binding and antibody production are indicated by lines. The accession numbers for the 
uncharacterised proteins shown are: Neurospora, CAB97305; Arabidopsis, C96829; Drosophila AAF46211. B. Sequence align-
ment of the C-terminal coiled coil domains of the proteins depicted in A.
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TMF is a Golgi protein
To localise TMF in animal cells, we raised antibodies to its
N terminus (residues 1–280). Immunoblotting of
cytosolic and Golgi fractions revealed one large protein
associated with the Golgi fraction (Figure 4A), consistent
with the reported apparent molecular weight of around
150 kDa for TMF [9]. Immunofluorescence with affinity-
purified antibodies showed staining typical of the Golgi
apparatus in COS cells, with a characteristic ring pattern
often seen with golgins (Figure 4B, untransfected). That
TMF is associated with Golgi markers was confirmed
using NRK cells (see below, Figure 4C). There was also
some faint staining of the nucleus in COS cells, but this
may represent a weak cross-reaction since it was detected
with only one of two different rabbit antisera. We investi-
gated localisation further by expressing an epitope-tagged
version of TMF in COS cells (Figure 4B). This again
showed Golgi staining, which could be detected identi-
cally with anti-TMF and anti-HA antibodies, attesting to
the specificity of the anti-TMF antibodies. However, the
anti-HA staining did not include the nucleus, and it was
striking that even in cells in which the protein was overex-
pressed, saturating its Golgi binding sites and causing
accumulation in the cytoplasm, it tended to be excluded
from the nucleus (fourth panel of Figure 4B). Expression
of a tagged version of the C-terminal Rab6-binding frag-
ment also resulted in Golgi localisation (Figure 4B),
though with this smaller protein some penetration of the
nucleus could be observed.
Reduced levels of TMF affect Golgi localisation
To test for a possible function of TMF in the Golgi, we
used RNAi to deplete it. Because depletion was inefficient
in COS cells, we used rat NRK cells for these experiments.
Some 10–15% of cells transfected with RNAi oligonucle-
otides showed significantly lowered levels of TMF, as
judged by immunofluorescence. We examined the distri-
bution in these cells of TGN38, a trans-Golgi network pro-
tein that recycles via endosomes [14,15], and thus might
be expected to require vesicular traffic to the Golgi to
Binding of TMF to Rab6 isoforms Figure 3
Binding of TMF to Rab6 isoforms A. Immunoblot showing the binding of the His-tagged C-terminal 310 residues of TMF to 
various GTPases, performed as in Figure 1. B. Coomassie stained gels showing the GTPases used in A, after elution from 
glutathione-Sepharose.
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Location and function of TMF Figure 4
Location and function of TMF A. Immunoblot of Golgi and cytosol fractions with anti-TMF antibodies. The Golgi lane con-
tained approximately 5 µg total protein, the cytosol lane approximately 100 µg protein. Marker positions (kDa) are indicated. 
B. Immunofluorescent images of COS cells showing endogenous TMF in an untransfected cell (untransf.), HA-tagged full-length 
protein expressed from a transfected plasmid (HA-TMF) and detected with both anti-HA and anti-TMF, as well as a cell 
expressing rather higher levels of HA-TMF (only the anti-HA image is shown; anti-TMF staining of this cell gave an identical pat-
tern). The last panel shows the HA-tagged 310 C-terminal residues of HA (HA-C term) expressed similarly and detected with 
anti-HA. Bar is 10 µm. C. Rat NRK cells transfected with RNAi and stained for TMF and either TGN38 or GOS28 as indicated. 
Note that TMF-depleted cells (green in the merged images) have more dispersed Golgi than the other cells. The insets in some 
panels show an enlarged region of the Golgi, boxed in the merged image. Bars are 10 µm.
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maintain its steady-state distribution. In untransfected
cells there was close coincidence of TGN38 and TMF stain-
ing, though often the TMF staining appeared to surround
or be adjacent to the TGN38 (see enlarged insets in Figure
4C). Strikingly, in those cells with relatively low levels of
TMF the Golgi frequently appeared more disperse than
usual (Figure 4C). Both TGN38 and, where visible, resid-
ual TMF were spread in a broad area around the nucleus.
Similar results were obtained when cells were stained for
GOS28, a SNARE protein found throughout the Golgi
stack [16] (Figure 4C). Thus, this phenomenon affects not
just the localisation of TGN38, but the compact organisa-
tion of the entire ribbon of Golgi stacks.
As the examples in Figure 4C show, NRK cells have varia-
ble Golgi morphology. Some have a single patch of
tightly-clustered Golgi membranes whereas others, pre-
sumably at a different stage of the cell cycle, have a more
drawn-out pattern around the nucleus. Defining a com-
pact Golgi structure by a simple criterion, namely that
Golgi membranes extend around no more than half the
nuclear periphery, we found that 58% of cells with nor-
mal levels of TMF had compact Golgi. In contrast, a com-
pact Golgi was observed in only 8% of cells with reduced
TMF, estimated from the relative ratio of TMF to TGN38
or GOS28 – that is, cells that appear green in Figure 4C.
Furthermore, cells with reduced TMF often had Golgi
membranes dispersed throughout the cytoplasm, rather
than immediately around the nucleus, as the examples in
Figure 4C illustrate. Such a broad spread was almost never
seen in normal cells, and conversely the pattern of a single
tight patch of Golgi, common in normal cells, was present
in less than 5% of the TMF-depleted cells. Thus, we con-
clude that TMF contributes to the large-scale organisation
of Golgi stacks.
Discussion
In this paper we have shown that TMF has similarities to
SGM1 in sequence, structure, ability to bind Rab6, and
Golgi location. Its properties place it clearly in the cate-
gory of golgins, and we can conclude that one function of
Rab6 is to recruit this golgin. Furthermore, TMF
contributes to the overall organisation of the Golgi stacks
in NRK cells, suggesting either that it helps them to adhere
to each other, or that it facilitates the cytoskeleton-
dependent movement of the stacks to their normal peri-
centriolar location. Interestingly, the only other Rab6-
binding golgin known is bicaudal-D, which binds dynac-
tin and has been suggested to mediate the movement of
Golgi membranes along microtubules [5]. Possibly, TMF
also contributes to this process. In contrast, Sgm1 appears
dispensable for Golgi function in budding yeast [8],
where Golgi membranes are neither stacked nor restricted
to a tight cluster. Golgi stacks are also typically dispersed
in Drosophila and plants. However, the presence in a
wide range of eukaryotes of proteins with a similar overall
structure, and a similar Rab6-binding domain, to that of
TMF and Sgm1 suggests that these proteins do play a use-
ful role. It may be that their precise functions differ in dif-
ferent species.
How do the properties of TMF relate to previous studies
that implicated it in nuclear roles? TMF has been inde-
pendently isolated four times. A fragment of it was first
found to bind a HIV1 TATA box DNA oligonucleotide in
a screen of bacteriophage-expressed proteins, but no in
vivo function in HIV transcription was demonstrated [9].
TMF was subsequently found in a yeast 2-hybrid screen as
a substrate for the FER nuclear tyrosine kinase, but again
no in vivo function or localisation was demonstrated [17].
Interestingly, however, expression of TMF was found to be
particularly high in meiotic germ cells; in Drosophila, sev-
eral mutations in components involved in Golgi transport
have been found to have phenotypes restricted largely to
such cells, probably because plasma membrane growth is
especially rapid during spermatogenesis [18]. Subse-
quently, TMF was re-isolated in a phage expression screen
using a peptide from the androgen receptor as a ligand,
and re-named ARA160 [10]. Functional assays showed
that strong overexpression of the protein could enhance
the activation of a reporter construct by nuclear hormone
receptors. This occurred only in certain cell types, even
though TMF is present in a wide range of tissues. Finally,
a second yeast 2-hybrid screen identified TMF as a binding
partner for hSNF2, a component of a chromatin remodel-
ling complex [11]. No functional role was demonstrated
for this interaction, and the authors found that most of
the protein was associated with the Golgi complex, as we
have observed.
These disparate studies fall short of proving a nuclear role
for TMF, but they do leave open the possibility that such
a role exists, perhaps only in certain cell types and/or for
a minor fraction or isoform of the protein that is specifi-
cally transported into nuclei. For example, several golgins
have been shown to be cleaved during the early stages of
apoptosis, resulting in Golgi fragmentation [19-21], and
in one case a cleavage product has been found to associate
with the nucleus [20]. We did observe some penetration
of the nucleus by the C terminal Rab6 binding domain
when this was expressed alone. However, in COS cells and
NRK cells we found little evidence that full-length TMF
could accumulate in nuclei. Given its homology to Sgm1
and other properties, we consider it likely that the primary
location and function of TMF lies in the Golgi.
Conclusions
We have shown that the mammalian protein TMF, previ-
ously thought to have a nuclear role, binds to the Golgi
GTPase Rab6 and contributes to Golgi organisation. ItBMC Cell Biology 2004, 5 http://www.biomedcentral.com/1471-2121/5/18
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shares an overall coiled-coil structure, as well as a separate
Rab6-binding coiled-coil domain, with the yeast protein
Sgm1 and with similar proteins in other eukaryotes. The
properties of TMF indicate that it should be considered
one of the class of Golgi-associated proteins termed
golgins.
Methods
Expression of Sgm1, TMF and Rab GTPases in E coli and in 
vitro binding experiments
His-tagged TMF fragments, and GST fusions to Rab6,
Rab1 and Ypt52 were expressed in E. coli, and protein A-
tagged Sgm1 fragments in yeast, as described previously
[8]. The cDNA for Rab6B was obtained from the MRC
HGMP resource centre, Hinxton, UK. Rab6A and Rab1
were gifts from Sean Munro, and Ypt52 a gift from Ewald
Hettema. The Rab6A' sequence was created by site-
directed mutageneisis of the Rab6A cDNA. The GST
fusions were bound to glutathione Sepharose, incubated
with GDP or GTPγS and then with E. coli extract (for His-
tagged TMF) or yeast extract (for protein A-tagged Sgm1),
followed by elution and analysis by immunoblotting as
described previously [8]. For rabbit antibody production,
the first 280 residues of TMF were expressed as a GST
fusion using the pGEX6P2 vector (Amersham). Antibod-
ies were affinity purified on the same fusion protein.
Cell culture and DNA transfections
COS and NRK cells were grown at 37°C in Dulbecco's
modified Eagle's medium (DMEM) supplemented with
10% fetal calf serum, ampicillin and streptomycin in 75-
c m  F a l c o n  f l a s k s  i n  a  h u m i d i f i e d  1 0 %  C O 2 incubator.
Transient expression of (HA)2TMF was from the CMV pro-
moter in pCMV2HATMF [17], kindly provided by Uri Nir.
The (HA)2TMF C-terminal domain was expressed simi-
larly. For this, cells were plated onto 6-well cell culture
clusters, and transfected with 1 µg/well of plasmid DNA,
using FUGENE6 (Roche) according to the manufacturer's
recommendations. Cells were fixed 40 h after transfection
as described below.
Immunolocalisation of TMF and Golgi markers
40 h after transfection, cells were fixed with 4% parafor-
maldehyde in PBS for 30 min, washed twice with PBS and
then permeabilised for 10 min in PBS supplemented with
0.5% Triton X-100, followed by a 30-min blocking with
20% foetal calf serum in PBS containing 0.5% Tween 20
(blocking solution). The cells were then incubated for 1 hr
at room temperature in a wet chamber in blocking solu-
tion containing affinity-purified rabbit anti TMF and/or
anti-HA mouse mAb 12CA5, or mouse mAbs specific for
TGN38 (a gift from P. Luzio) or GOS28 (Transduction
Labs) as required. The binding of the antibodies was
detected with Alexa 543-conjugated anti-rabbit IgG anti-
body and FITC fluorescein-conjugated anti-mouse. After
each antibody incubation, the cells were washed twice
with PBS/Tween, incubated with blocking solution for 5
min and again washed twice with PBS/Tween. Immun-
ofluorescence was then analysed with a BioRad Radiance
or MRC600 confocal microscope.
Preparation of Golgi membranes
Rat liver were homogenised, equilibrated in 0.5 M phos-
phate-buffered sucrose and layered on top of a phosphate-
buffered 0.86 M sucrose cushion. The homogenate was
overlaid with phosphate-buffered 0.25 M sucrose and
centrifuged at 105,000 × g for 60 min at 4°C. The Golgi
membranes were collected from the 0.5 M/0.86 M sucrose
interface, diluted to 0.25 M sucrose and pelleted by cen-
trifugation at 6000 × g for 20 min at 4°C. Cytosol proteins
were recovered from the 0.5 M sucrose layer.
RNAi Transfections
Oligonucleotides used for knock-down of TMF were as
follows: sense 5'-CAGGUCCUUGAUGGCAAAGdTdT-3'
and its antisense: 5'-CUUUGCCAUCAAGGACCUGdTdT-
3'. The sense and antisense RNA oligonucleotides (0.1
mM) in 100 mM potassium acetate, 30 mM HEPES-KOH
(pH 7.4) and 2 mM magnesium acetate, were heated to
90°C for 1 min, then cooled and annealed at 37°C for 1
hr. NRK cells were grown to 50% confluence and were
transfected with the annealed RNAi using the reagent
Oligofectamine (GIBCOBRL) following the manufac-
turer's protocol. Cells were fixed 40 h after transfection as
described above. Repeated transfection of RNAi did not
increase the frequency of cells with depleted TMF.
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